28 Feb 2016
Washington: A new malaria vaccine candidate was found to generate robust immune response while significantly delaying parasitemia in 59 per cent of vaccinated subjects, according to a first-of-its-kind in human study.
19 Nov 2015
Washington: A clinical trial of a new Ebola vaccine has found that it is well tolerated and stimulates strong immune responses in adults in Mali, West Africa and in US, scientists say.
07 May 2016
Washington: T cells, the security guards of the immune system, use a kind of mechanical 'handshake' to test whether a cell they encounter is a friend or foe, according to a new study that may help develop immune therapies for cancer.
06 May 2016
New Delhi: The Centre has released Rs 9,367 crore to drought-hit states under MGNREGA in 2016-17, Parliament was informed today.
04 Apr 2015
Washington: A new vaccine improves the immune system's response to cancer by using altered forms of proteins from the patient, according to a study published by the journal Science.
20 Jun 2015
Washington: An experimental vaccine candidate may have the potential to stimulate the immune system to block HIV infection, according to new research.
06 Jan 2015
New York: Various microorganisms that naturally colonize the skin may help protect us from infections as they trigger specific responses in the skin immune system to fight invasion by pathogens, a new research, involving an Indian-origin scientist, has found.
02 May 2016
New Delhi: Latest satellite imageries of Uttarakhand have reported that the forest fire has gone out in over 70 percent of the affected areas, even as the NDRF has deployed over 130 personnel to tackle the massive blaze.
26 Apr 2016
New Delhi: Delhi government rolled out special air-conditioned bus service for Members of Parliament (MPs) to ferry them to and fro during the on-going odd-even car rationing scheme but had to withdraw a majority of the buses within hours due to poor response from parliamentarians.
29 Jan 2015
London: The first trial results of Ebola vaccine at Oxford University suggest the vaccine has an acceptable safety profile and is able to generate an immune response."The Ebola vaccine was well tolerated. Its safety profile is pretty much as we had hoped," said professor Adrian Hill of the Jenner Institute at Oxford University who led the trial.